HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nomilin as an anti-obesity and anti-hyperglycemic agent.

Abstract
Recent scientific findings support the notion that bile acids, which are cholesterol catabolites, are bioactive signaling molecules that function as ligands for the farnesoid X receptor or a G-protein-coupled receptor, TGR5. Through these receptors, bile acids can maintain not only bile acid homeostasis but also lipid and carbohydrate homeostasis. An intriguing finding regarding the role of TGR5 in energy metabolism and glucose homeostasis suggests a potential approach to combat obesity and insulin resistance by targeting this receptor to increase thermogenesis and incretin secretion. In this review, I have summarized the latest findings related to TGR5 agonists, in particular, a citrus limonoid, nomilin, and the roles of these agonists in energy metabolism and glucose homeostasis.
AuthorsRyuichiro Sato
JournalVitamins and hormones (Vitam Horm) Vol. 91 Pg. 425-39 ( 2013) ISSN: 0083-6729 [Print] United States
PMID23374727 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
CopyrightCopyright © 2013 Elsevier Inc. All rights reserved.
Chemical References
  • Anti-Obesity Agents
  • Benzoxepins
  • Hypoglycemic Agents
  • Limonins
  • nomilin
Topics
  • Animals
  • Anti-Obesity Agents (pharmacology)
  • Benzoxepins (pharmacology)
  • Diabetes Mellitus (drug therapy)
  • Humans
  • Hypoglycemic Agents (pharmacology)
  • Limonins (pharmacology)
  • Obesity (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: